Jul 30, 2026 07:35AM

Apr 29, 2026 04:15PM

Feb 26, 2026 07:30AM

Jan 5, 2026 07:00AM

Jan 5, 2026 07:00AM

Dec 4, 2025 06:35AM

Dec 4, 2025 06:35AM Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tu

Nov 6, 2025 07:30AM

May 9, 2022 08:30AM

Mar 31, 2022 08:00AM

Mar 16, 2022 09:26AM

Mar 15, 2022 05:51PM

Jan 25, 2022 08:04AM

Jan 25, 2022 08:00AM Catalyst Biosciences Receives Rare Pediatric Disease Designation for CB 4332 for the Treatment of CFI Deficiency

Sep 28, 2021 04:03PM

Sep 28, 2021 04:01PM

Aug 5, 2021 08:00AM

Jun 28, 2021 08:08AM

Jun 28, 2021 08:00AM

Mar 4, 2021 08:00AM

Dec 2, 2020 08:03AM Catalyst Biosciences (CBIO) Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Hemophilia A or B with Inhibitors

Dec 2, 2020 08:00AM

Aug 18, 2020 04:30PM

Jun 22, 2020 04:05PM

Jun 22, 2020 08:00AM

Jun 19, 2020 11:48AM

Jun 19, 2020 11:45AM

Jun 18, 2020 09:26AM Pre-Open Stock Movers 06/18: (ALPN) (AEMD) (ELOX) Higher; (LPTX) (QUIK) (BIIB) Lower (more...)

Jun 18, 2020 09:09AM

Jun 18, 2020 09:00AM

Jun 17, 2020 04:03PM

Jun 17, 2020 04:01PM

Jun 15, 2020 08:05AM

Jun 15, 2020 08:00AM

Jun 15, 2020 07:02AM Catalyst Biosciences (CBIO) Reports Positive Final Data from Ph. 2b Trial of Subcutaneous Dalcinonacog Alfa (DalcA)

Jun 15, 2020 07:00AM

Jun 12, 2020 08:00AM

Jun 10, 2020 08:10AM

Jun 10, 2020 08:00AM

Jun 8, 2020 08:00AM

May 11, 2020 08:00AM

Apr 28, 2020 08:06AM Catalyst Biosciences (CBIO) Receives Patent in European Union for Its Factor IX Portfolio

Apr 28, 2020 08:00AM

Apr 6, 2020 08:10AM

Apr 6, 2020 08:00AM

Feb 20, 2020 04:05PM

Nov 7, 2019 08:00AM

Aug 1, 2019 08:00AM

Jul 8, 2019 05:55AM Catalyst Biosciences (CBIO) Meets Primary Endpoint of Reduction in Annualized Bleeding Rate in the Phase 2 Trial of Subcutaneous Marzeptacog Alfa (Activated)

Jul 8, 2019 05:00AM

328,342 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All